SEC 13F Intelligence

Johnson Investment Counsel Inc / ABBV

Johnson Investment Counsel Inc’s Abbvie Inc Position

Does Johnson Investment Counsel Inc own Abbvie Inc (ABBV)? Yes158.2K shares worth $34M (+0.28% of its 13F portfolio) as of Q1 2026, up from 157.1K shares the prior filed quarter.

Position Value
$34M
Q1 2026
Shares
158.2K
% of Portfolio
+0.28%
Quarters Held
24
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $13MQ4 ’18Q1 ’19: $12MQ2 ’19: $10MQ3 ’19: $11MQ3 ’19Q4 ’19: $12MQ2 ’20: $14MQ3 ’20: $12MQ3 ’20Q4 ’20: $15MQ1 ’21: $16MQ2 ’21: $16MQ2 ’21Q3 ’21: $15MQ1 ’22: $24MQ2 ’22: $22MQ2 ’22Q3 ’22: $20MQ4 ’22: $24MQ1 ’23: $23MQ1 ’23Q2 ’23: $20MQ1 ’24: $28MQ4 ’24: $28MQ4 ’24Q1 ’25: $34MQ2 ’25: $29MQ3 ’25: $37MQ3 ’25Q4 ’25: $36MQ1 ’26: $34Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026158.2K$34M+0.28%
Q4 2025157.1K$36M+0.29%
Q3 2025158.7K$37M+0.31%
Q2 2025156.5K$29M+0.26%
Q1 2025161.8K$34M+0.33%
Q4 2024156.5K$28M+0.27%
Q1 2024152.2K$28M+0.30%
Q2 2023147.4K$20M+0.25%
Q1 2023145.3K$23M+0.31%
Q4 2022146.0K$24M+0.32%
Q3 2022150.2K$20M+0.30%
Q2 2022146.3K$22M+0.32%
Q1 2022146.3K$24M+0.29%
Q3 2021143.5K$15M+0.21%
Q2 2021141.3K$16M+0.23%
Q1 2021143.4K$16M+0.23%
Q4 2020142.3K$15M+0.25%
Q3 2020141.6K$12M+0.23%
Q2 2020142.6K$14M+0.28%
Q4 2019139.8K$12M+0.23%
Q3 2019141.9K$11M+0.21%
Q2 2019143.3K$10M+0.22%
Q1 2019143.4K$12M+0.25%
Q4 2018141.9K$13M+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Johnson Investment Counsel Inc’s full portfolio or all institutional holders of ABBV.